| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention refers to prevention and treatment of pancreatic diabetes type 2. To delay disease development or to provide early stage treatment such inhibitors of dipeptidylpeptidase IV are selected as to supply optimal inhibition constant. For this purpose (2S)-1 -((2'S)-2' -amino-3' ,3' -dimethylbutanoil) pyrrolidine-2-carbonitryl or its pharmaceutically accepted salt, or (2S)-l-((2'S)-2'-amino-5'-pyrazincarbonylaminopentanoil)pyrrolidine-2-carbonitryl or its pharmaceutically accepted salt. ^ EFFECT: improved prevention of diabetes and related complications. ^ 3 cl, 7 dwg, 3 ex |
